Suppr超能文献

利用微生物效应器实现巨噬细胞介导的药物递送。

Harnessing Microbial Effectors for Macrophage-Mediated Drug Delivery.

作者信息

Van Staden Anton Du Preez, Visser Johan G, Powrie Yigael S L, Smith Carine

机构信息

Department of Microbiology, Science Faculty, Stellenbosch University, Stellenbosch 7600, South Africa.

Experimental Medicine Research Group, Department of Medicine, Faculty of Medicine and Health Sciences, Stellenbosch University, Parow 7505, South Africa.

出版信息

ACS Omega. 2024 Apr 11;9(16):18260-18272. doi: 10.1021/acsomega.3c10519. eCollection 2024 Apr 23.

Abstract

Macrophage-based drug delivery systems are promising, but their development is still in its infancy, with many limitations remaining to be addressed. Our aim was to design a system harnessing microbial effectors to facilitate controlled drug cargo expulsion from macrophages to enable the use of more toxic drugs without adding to the risk of off-target detrimental effects. The pore forming and actin polymerizing effectors listeriolysin-O (LLO) and actin assembly-inducing protein (ActA) were synthesized using a novel green fluorescent protein (GFP)-linked heterologous expression system. These effectors were coated onto polystyrene beads to generate "synthetic cargo" before loading into primary M1 macrophages. Bead uptake and release from macrophages were evaluated by using high-throughput quantitative imaging flow cytometry and confocal microscopy. results confirmed appropriate activity of synthesized effectors. Coating of these effector proteins onto polystyrene beads (simulated drug cargo) resulted in changes in cellular morphology, bead content, and intracellular bead localization, which may support an interpretation of the induced release of these beads from the cells. This forms the basis for further investigation to fully elucidate any potential release mechanisms. Bacterial effectors ActA and LLO successfully effectuated actin polarization and protrusions from cell membranes similar to those seen in cells infected with spp., illustrating the potential of using these effectors and production methods for the development of an endogenous drug delivery system capable of low-risk, targeted release of high potency drugs.

摘要

基于巨噬细胞的药物递送系统前景广阔,但其发展仍处于起步阶段,存在许多有待解决的局限性。我们的目标是设计一种利用微生物效应蛋白的系统,以促进药物从巨噬细胞中可控释放,从而能够使用毒性更强的药物,同时又不增加脱靶有害效应的风险。利用一种新型的绿色荧光蛋白(GFP)连接的异源表达系统合成了成孔和诱导肌动蛋白聚合的效应蛋白——李斯特菌溶血素-O(LLO)和肌动蛋白组装诱导蛋白(ActA)。在将这些效应蛋白加载到原代M1巨噬细胞之前,先将它们包被在聚苯乙烯珠上以生成“合成药物载体”。通过高通量定量成像流式细胞术和共聚焦显微镜评估珠子被巨噬细胞摄取和释放的情况。结果证实了合成效应蛋白具有适当的活性。将这些效应蛋白包被在聚苯乙烯珠(模拟药物载体)上导致细胞形态、珠子含量和细胞内珠子定位发生变化,这可能支持对这些珠子从细胞中诱导释放的解释。这为进一步研究以充分阐明任何潜在的释放机制奠定了基础。细菌效应蛋白ActA和LLO成功地实现了肌动蛋白极化和细胞膜突起,类似于感染了 菌的细胞中观察到的情况,这说明了利用这些效应蛋白和生产方法开发一种能够低风险、靶向释放高效药物的内源性药物递送系统的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f90/11044259/df03fbb32327/ao3c10519_0001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验